Researchers look to the gut to boost cancer immunotherapy's fighting power

by Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainCancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patie

Updated on: January 30,2024

Researchers look to the gut to boost cancer immunotherapy's fighting power

by Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainCancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patie

Updated on:January 30,2024

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI

Updated on: February 18,2024

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI

Updated on:February 18,2024

Treatment found to reduce progression of rare blood cancer by 74%

Credit: Wikimedia CommonsA treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type

Updated on: January 29,2024

Treatment found to reduce progression of rare blood cancer by 74%

Credit: Wikimedia CommonsA treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type

Updated on:January 29,2024

Newly developed inhibitor shows potential for prostate cancer

JANUARY 9, 2024byAlbert Ludwigs University of FreiburgIdentification of a bi-substrate inhibitor of KMT9.aChemical structure of compound1awith predicted binding mode.&nbs

Updated on: March 25,2024

Newly developed inhibitor shows potential for prostate cancer

JANUARY 9, 2024byAlbert Ludwigs University of FreiburgIdentification of a bi-substrate inhibitor of KMT9.aChemical structure of compound1awith predicted binding mode.&nbs

Updated on:March 25,2024

Substance use disorders on the rise for survivors of specific cancers

by Elana GotkineThe prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 inJAMA Oncology.Kati

Updated on: March 05,2024

Substance use disorders on the rise for survivors of specific cancers

by Elana GotkineThe prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 inJAMA Oncology.Kati

Updated on:March 05,2024

Study points to practice-changing care for patients with refractory metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainJosep Tabernero, Director of the Vall d'Hebron Institute of Oncology (VHIO), presented data from the international phase

Updated on: February 23,2024

Study points to practice-changing care for patients with refractory metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainJosep Tabernero, Director of the Vall d'Hebron Institute of Oncology (VHIO), presented data from the international phase

Updated on:February 23,2024

AI model identifies certain breast tumor stages likely to progress to invasive cancer

by Adam ZeweA large-scale high-resolution chromatin imaging dataset enables the analysis of disease stages and phenotypic categories in DCIS. Credit:Nature Communications(2024). DOI: 10.10

Updated on: August 03,2024

AI model identifies certain breast tumor stages likely to progress to invasive cancer

by Adam ZeweA large-scale high-resolution chromatin imaging dataset enables the analysis of disease stages and phenotypic categories in DCIS. Credit:Nature Communications(2024). DOI: 10.10

Updated on:August 03,2024

A new therapeutic target against the most common lung cancer

by University of BarcelonaFrom left to right: Marselina Arshakyan, Elba Marín (front), Paula Duch, Cristina Teixidó, Noemí Reguart, Rafael Ikemori, Jordi Alcaraz, Marta Gabasa and Natalia Díaz. C

Updated on: February 23,2024

A new therapeutic target against the most common lung cancer

by University of BarcelonaFrom left to right: Marselina Arshakyan, Elba Marín (front), Paula Duch, Cristina Teixidó, Noemí Reguart, Rafael Ikemori, Jordi Alcaraz, Marta Gabasa and Natalia Díaz. C

Updated on:February 23,2024

Researchers identify mechanism involved in development and intensification of cancer treatment-related pain

by Luciana Constantino,FAPESPCredit: Pixabay/CC0 Public DomainA combination of chemotherapy and drugs that stimulate the immune system to combat cancer is increasingly used to control progressio

Updated on: February 18,2024

Researchers identify mechanism involved in development and intensification of cancer treatment-related pain

by Luciana Constantino,FAPESPCredit: Pixabay/CC0 Public DomainA combination of chemotherapy and drugs that stimulate the immune system to combat cancer is increasingly used to control progressio

Updated on:February 18,2024

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl

Updated on: January 30,2024

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl

Updated on:January 30,2024

Infections from a diarrhea-causing parasite are on the rise in the UK, but experts aren't quite sure why

by Paul Hunter,The ConversationLaboratory notifications of Cryptosporidium species in England, Wales and Northern Ireland, by week of specimen, 2023. Credit:Eurosurveillance(2023). D

Updated on: April 20,2024

Infections from a diarrhea-causing parasite are on the rise in the UK, but experts aren't quite sure why

by Paul Hunter,The ConversationLaboratory notifications of Cryptosporidium species in England, Wales and Northern Ireland, by week of specimen, 2023. Credit:Eurosurveillance(2023). D

Updated on:April 20,2024

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e

Updated on: February 20,2024

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e

Updated on:February 20,2024